Inventiva S.A Operating Expenses 2020-2024 | IVA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Inventiva S.A operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Inventiva S.A operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$214.8B
Amgen (AMGN)	$160.4B
Gilead Sciences (GILD)	$135.3B
Vertex Pharmaceuticals (VRTX)	$119B
Bristol Myers Squibb (BMY)	$97.8B
CSL (CSLLY)	$78.3B
GSK (GSK)	$74.7B
Regeneron Pharmaceuticals (REGN)	$59.4B
Alnylam Pharmaceuticals (ALNY)	$42.3B
Argenex SE (ARGX)	$35B
BioNTech SE (BNTX)	$26.7B
Royalty Pharma (RPRX)	$19.9B
Insmed (INSM)	$19.8B
Biogen (BIIB)	$18.9B
Illumina (ILMN)	$15.5B
Genmab (GNMSF)	$14.5B
Genmab (GMAB)	$14.1B
Incyte (INCY)	$13.3B
Moderna (MRNA)	$12.5B
Exelixis (EXEL)	$12.2B
BioMarin Pharmaceutical (BMRN)	$11.2B
Ascendis Pharma (ASND)	$10.8B
QIAGEN (QGEN)	$10.7B
Swedish Orphan Biovitrum (BIOVF)	$10.6B
Exact Sciences (EXAS)	$9.8B
Verona Pharma American Depositary Share (VRNA)	$8.9B
Bio-Techne Corp (TECH)	$8.4B
Blueprint Medicines (BPMC)	$8.3B
Roivant Sciences (ROIV)	$7.9B
Legend Biotech (LEGN)	$7.7B